Doug Hampton

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

by

Elucidated molecular mechanism behind safety and efficacy of Bersiporocin Bersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary Fibrosis SEOUL, South Korea, May 25, 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for … Read more

Dizal’s Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting

by

SHANGHAI, May 25, 2023 /PRNewswire/ — Dizal (688192.SH) today announced that data from its oncology portfolio will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, 2023 in Chicago. The data which include updated analyses of Dizal’s two leading assets – sunvozertinib (a selective EGFR TKI targeting a wide … Read more

Increasing Rates of Hereditary Disorders and Chronic Diseases to Boost Growth

by

DUBLIN, May 25, 2023 /PRNewswire/ — The “Regenerative Medicine Market – Forecasts from 2022 to 2027” report has been added to  ResearchAndMarkets.com’s offering. The regenerative medicine market is estimated to be valued at US$19.322 billion in 2020. Companies Mentioned Novartis Amgen Bluebird Bio GSK plc. Shenzhen Sibiono Genetech Anterogen CO., LTD. Chiesi Farmaceutici S.p.a. Jcr Pharmaceuticals … Read more

Need for Industrial Cleaners is Anticipated to Increase Across a Variety of Manufacturing Industries

by

DUBLIN, May 25, 2023 /PRNewswire/ — The “Industrial Cleaning Market – Forecasts from 2023 to 2028” report has been added to  ResearchAndMarkets.com’s offering. The global industrial cleaning market is anticipated to expand at a compound annual growth rate of 4.84% during the projected period, from a market value of US$49.684 billion in 2021 to US$69.176 billion … Read more

Vial to Sponsor and Exhibit at BIO International Convention 2023, Showcasing Next-Generation CRO Services

by

SAN FRANCISCO, May 25, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be a sponsor and exhibitor at the 2023 BIO International Convention in Boston, MA, June 5-8, 2023. The conference will offer a range of valuable opportunities, including one-on-one partnering for business growth, networking events to … Read more

Invitae Announces CFO Transition and Selection of Veteran Finance Executive Christine Gorjanc as Interim CFO

by

SAN FRANCISCO, May 25, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Chief Financial Officer (CFO) Yafei (Roxi) Wen is resigning to pursue other opportunities, effective June 30, 2023. The Company has initiated a search for a new CFO. Ms. Wen will continue in her role through the end of the second … Read more

Huma named for its successful and innovative approach to clinical trials in new UK government review

by

Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more

Presentan novedoso método para atender las adicciones; by Juan Carlos Machorro

by

CIUDAD DE MEXICO, 25 de mayo de 2023 /PRNewswire/ — Se dio a conocer la llegada a México del Método Abrahamson, creado en Israel. Al respecto, Arie Reboot, explica que dicho sistema de salud es el único tratamiento energético que ha ayudado a las personas a liberarse de adicciones, así como restablecer la vitalidad y … Read more

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

by

Elucidated molecular mechanism behind safety and efficacy of Bersiporocin Bersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary Fibrosis SEOUL, South Korea, May 25, 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for … Read more

Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract

by

31% week-16 overall response rate and 9.6-month median progression-free survival with pelareorep plus paclitaxel vs. 20% and 6.4 months with paclitaxel alone as of Oct. 2022 ASCO abstract cut-off date Updated data from May 2023 cut-off date will be presented in an oral presentation on June 3, 2023 Oncolytics to advance to registrational study of pelareorep-paclitaxel … Read more